Efficacy and Safety of Cerebrolysin as an Adjunct to Mechanical Thrombectomy in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis of Observational Studies
Review of earlier studies · 2026
- What was studied
- 2026 review of three observational thrombectomy-adjunct studies
- Main finding
- Authors report favorable recovery and safety associations, but inconsistent denominators prevent reliable interpretation of the quoted estimates.
Study data at a glance
- Participants or experimental model
- 2026 review of three observational thrombectomy-adjunct studies
- Reported results
- Authors report favorable recovery and safety associations, but inconsistent denominators prevent reliable interpretation of the quoted estimates.
Study limitations and source details
Study limitations
- Table 1 totals 148 treated and 146 controls, while the abstract gives incompatible functional-outcome and mortality denominators.
- Mortality is pooled across several follow-up times; independence of repeated observations needs verification. Staszewski is dated 2025 in Table 1 but 2022 in the results.
- Three observational cohorts cannot establish a randomized adjunct effect. The original datasets are needed before relying on the pooled numbers.
Source details
Full PMC article: study-characteristic tables and results narrative checked. Original cohort records and repeated follow-up observations still require reconstruction.
Full-text reporting checks; reconstruction pending
Sources checked
Citation
Afridi A, Sajjad F, Arshad A, Shahid I, Fatima NE, Alam U, Hoti RK, Abdullah M, Khan S, GhanimAl-Badri S, Khan S, Bakkar MA, Saeed A, Ali A, Khan LA, Kamil KA. Efficacy and Safety of Cerebrolysin as an Adjunct to Mechanical Thrombectomy in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis of Observational Studies Brain and behavior · PMID 41880098
Study source ↗ · DOI 10.1002/brb3.71252 · Bibliography entry · Link to this summary